Latest News Clearside Biomedical Names Carol Hoang as Vice President, Medical Affairs By Staff Friday, July 13, 2018 12:21 AM ALPHARETTA, Ga.—Clearside Biomedical, Inc. has announced the appointment of Carol Hoang, Pharm.D., MBA, to the position of vice president, medical affairs. Dr. Hoang brings over 17 years of experience across multiple sectors of the global health care industry to Clearside. Before joining Clearside, Dr. Hoang was vice president, medical affairs for DigiSight Technologies, Inc. She also held the position of global executive medical director at Novartis Pharma AG, and also held the senior marketing and medical affairs positions at Genetech, Inc. In addition to this, Dr. Hoang’s previous experience includes various roles at Oncology Therapeutics Network, a subsidiary of Bristol-Myers Squibb Company and at CVS Caremark, the prescription benefit management subsidiary of CVS Health. “Carol is a seasoned executive with a strong track record of success managing medical affairs for both large and emerging ophthalmic companies,” said Clearside’s chief executive officer and president, Daniel H. White. “Her ability to build advocacy and create compelling scientific communication platforms will be a tremendous asset as we continue to plan for Clearside’s potential transition from a clinical-stage to a commercial-stage company.”Dr. Hoang earned her dual Pharm.D/MBA from the University of Southern California.